, Tracking Stock Market Picks
Enter Symbol:
Cemex S.a.b. De C.v. (CX) [hlAlert]

Equal Weight
down 26.13 %

Cemex S.a.b. De C.v. (CX) rated Equal Weight with price target $9 by Barclays

Posted on: Friday,  Oct 23, 2015  3:25 PM ET by Barclays

Barclays rated Equal Weight Cemex S.a.b. De C.v. (NYSE: CX) on 10/23/2015. Previously Barclays rated Overweight Cemex S.a.b. De C.v. (NYSE: CX)
on 06/19/2013., when the stock price was $10.40. Since then, Cemex S.a.b. De C.v. has lost 26.13% as of 10/23/2015's recent price of $7.68.
If you would have followed the previous Barclays's recommendation on CX, you would have lost 26.13% of your investment in 856 days.

CEMEX, S.A.B. de C.V. (CEMEX) is a Mexico-based holding company of entities whose main activities are oriented to the construction industry, through the production, marketing, distribution and sale of cement, ready-mix concrete, aggregates and other construction materials. CEMEX is a global cement manufacturer with operations in North America, Europe, South America, Central America, the Caribbean, Africa, the Middle East, Australia and Asia. The Company, through its operating subsidiaries, is engaged in the production, distribution, marketing and sale of cement, ready-mix concrete, aggregates and clinker. As of December 31, 2008, the Company?s main cement production facilities were located in Mexico, the United States, Spain, the United Kingdom, Germany, Poland, Croatia, Latvia, Colombia, Costa Rica, the Dominican Republic, Panama, Nicaragua, Puerto Rico, Egypt, the Philippines and Thailand. On December 26, 2008, the Company sold its Canary Islands operations.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/23/2015 3:25 PM Buy
6.97 9.00
as of 8/27/2015
1 Week up  2.67 %
1 Month down  -20.57 %
3 Months down  -25.79 %
1 YTD down  -32.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/2/2013 1:25 PM Buy
11.55 12.48
6/19/2013 1:25 PM Buy
10.40 11.52

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy